Search Results - "SMELAND, Sigbjorn"

Implementing cancer patient pathways in Scandinavia how structuring might affect the acceptance of a politically imposed reform by Mæhle, Per Magnus, Smeland, Sigbjørn

“…•Similar reform in cancer care was implemented top-down well received and perceived as a success by the professional communities.•This can be explained by a…”
Get full text

Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis by COLLINS, Mamie, WILHELM, Miriam, FERRARI, Stefano, PICCI, Piero, SMELAND, Sigbjørn, ERIKSSON, Mikael, PETRILLI, Antonio Sérgio, BLEYER, Archie, THOMAS, David M, CONYERS, Rachel, HERSCHTAL, Alan, WHELAN, Jeremy, BIELACK, Stefan, KAGER, Leo, KÜHNE, Thomas, SYDES, Matthew, GELDERBLOM, Hans

“…The LIVESTRONG Young Adult Alliance has conducted a meta-analysis of individual patient data from prospective neoadjuvant chemotherapy osteosarcoma studies and…”
Get full text

Self‐reported distress and problems after treatment for gynecological cancer – Correlation between a short screening tool and longer measures of anxiety/depression and health‐related quality of life by Skaali, Tone, Blomhoff, Rune, Lindemann, Kristina, Smeland, Sigbjørn, Bruheim, Kjersti, Seland, Mette, Thorsen, Lene

“…Introduction The National Comprehensive Cancer Network (NCCN) distress thermometer and problem list (DTPL) is a brief self‐report screening measure for use in…”
Get full text

Effect of a personalized intensive dietary intervention on base excision repair (BER) in colorectal cancer patients: Results from a randomized controlled trial by Nordengen, Anne Lene, Zheng, Congying, Krutto, Annika, Kværner, Ane S., Alavi, Dena T., Henriksen, Hege B., Henriksen, Christine, Smeland, Sigbjørn, Bøhn, Siv K., Paur, Ingvild, Shaposhnikov, Sergey, Collins, Andrew R., Blomhoff, Rune

“…DNA repair is essential to maintain genomic integrity and may affect colorectal cancer (CRC) patients’ risk of secondary cancers, treatment efficiency, and…”
Get full text

Outcome of rare primary malignant bone sarcoma (RPMBS) treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S) by Palmerini, Emanuela, Reichardt, Peter, Hall, Kirsten Sundby, Bertulli, Rossella, Bielack, Stefan S, Comandone, Alessandro, Egerer, Gerlinde, Hansmeier, Anna, Kevric, Matthias, Carretta, Elisa, Hansson, Lina, Jebsen, Nina, Eriksson, Mikael, Bruland, Øyvind S, Donati, Davide Maria, Ibrahim, Toni, Smeland, Sigbjørn, Ferrari, Stefano

“…Rare primary malignant bone sarcomas (RPMBS) account for 5%-10% of primary high-grade bone tumors and represent a major treatment challenge. The outcome of…”
Get full text

Cancer risk with folic acid supplements: a systematic review and meta-analysis by Wien, Tale Norbye, Pike, Eva, Wisløff, Torbjørn, Staff, Annetine, Smeland, Sigbjørn, Klemp, Marianne

“…ObjectiveTo explore if there is an increased cancer risk associated with folic acid supplements given orally.DesignSystematic review and meta-analysis of…”
Get full text

Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1 by Kolberg, Matthias, Høland, Maren, Agesen, Trude H, Brekke, Helge R, Liestøl, Knut, Hall, Kirsten S, Mertens, Fredrik, Picci, Piero, Smeland, Sigbjørn, Lothe, Ragnhild A

“…There are conflicting reports as to whether malignant peripheral nerve sheath tumor (MPNST) patients with neurofibromatosis type 1 (NF1) have worse prognosis…”
Get full text

Rituximab‐treated patients with lymphoma develop strong CD8 T‐cell responses following COVID‐19 vaccination by Riise, Jon, Meyer, Saskia, Blaas, Isaac, Chopra, Adity, Tran, Trung T., Delic‐Sarac, Marina, Hestdalen, Malu Lian, Brodin, Ellen, Rustad, Even Holth, Dai, Ke‐Zheng, Vaage, John Torgils, Nissen‐Meyer, Lise Sofie Haug, Sund, Fredrik, Wader, Karin F., Bjornevik, Anne T., Meyer, Peter A., Nygaard, Gro O., König, Marton, Smeland, Sigbjørn, Lund‐Johansen, Fridtjof, Olweus, Johanna, Kolstad, Arne

“…Summary B‐cell depletion induced by anti‐cluster of differentiation 20 (CD20) monoclonal antibody (mAb) therapy of patients with lymphoma is expected to impair…”
Get full text

Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study by Hompland, Ivar, Ferrari, Stefano, Bielack, Stefan, Palmerini, Emanuela, Hall, Kirsten S., Picci, Pierro, Hecker-Nolting, Stefanie, Donati, Davide M., Blattmann, Claudia, Bjerkehagen, Bodil, Staals, Eric, Kager, Leo, Gambarotti, Marco, Kühne, Thomas, Eriksson, Mikael, Ferraresi, Virginia, Kevric, Matthias, Biagini, Roberto, Baumhoer, Daniel, Brosjø, Otte, Comandone, Alessandro, Schwarz, Rudolf, Bertulli, Rossella, Kessler, Torsten, Hansson, Lina, Apice, Gaetano, Heydrich, Björn-N., Setola, Elisabetta, Flörcken, Anne, Ruggieri, Pietro, Krasniqi, Fatime, Hofmann-Wackersreuther, Gerda, Casali, Paolo, Reichardt, Peter, Smeland, Sigbjørn

“…The role of chemotherapy for patients with dedifferentiated chondrosarcoma (DDCS) is still under discussion. Here, we present the outcome in patients with DDCS…”
Get full text

Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma by Budde, Axel, Baust, Katja, Weinhold, Leonie, Bernstein, Mark, Bielack, Stefan, Dhooge, Catharina, Hjorth, Lars, Janeway, Katherine A., Jenney, Meriel, Krailo, Mark D., Marina, Neyssa, Nagarajan, Rajaram, Smeland, Sigbjørn, Sydes, Matthew R., De Vos, Patricia, Whelan, Jeremy, Wiener, Andreas, Calaminus, Gabriele, Schmid, Matthias

“…The available questionnaires for quality-of-life (QoL) assessments are age-group specific, limiting comparability and impeding longitudinal analyses. The…”
Get full text

The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions by Schlander, Michael, van Harten, Wim, Retèl, Valesca P, Pham, Phu Duy, Vancoppenolle, Julie M, Ubels, Jasper, López, Olaya Seoane, Quirland, Camila, Maza, Felipe, Aas, Eline, Crusius, Bernd, Escobedo, Agustín, Franzen, Nora, Fuentes-Cid, Jeanette, Hernandez, Diego, Hernandez-Villafuerte, Karla, Kirac, Iva, Paty, Artus, Philip, Thierry, Smeland, Sigbjørn, Sullivan, Richard, Vanni, Elena, Varga, Sinisa, Vermeulin, Thomas, Eckford, Rachel D

“…Loss of income and out-of-pocket expenditures are important causes of financial hardship in many patients with cancer, even in high-income countries. The…”
Get full text

Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma by Budde, Axel, Baust, Katja, Weinhold, Leonie, Bernstein, Mark, Bielack, Stefan, Dhooge, Catharina, Hjorth, Lars, Janeway, Katherine A, Jenney, Meriel, Krailo, Mark D, Marina, Neyssa, Nagarajan, Rajaram, Smeland, Sigbjørn, Sydes, Matthew R, De Vos, Patricia, Whelan, Jeremy, Wiener, Andreas, Calaminus, Gabriele, Schmid, Matthias

Get full text

Long-term satisfaction with curative treatment and follow-up in prostate cancer survivors by Monsen, Kari V, Fosså, Sophie D, Myklebust, Tor Å, Smeland, Sigbjørn, Dahl, Alv A, Stensvold, Andreas

“…In a cross-sectional observational study to explore long-term satisfaction with treatment among men who had undergone radical prostatectomy (RP) or definitive…”
Get more information

Mind the Differences: How Diagnoses and Hospital Characteristics Influence Coordination in Cancer Patient Pathways by Mæhle, Per Magnus, Hanto, Ingrid Kristine Small, Simensen, Victoria Charlotte, Smeland, Sigbjørn

“…Integrated care pathway (ICP) is a prevailing concept in health care management including cancer care. Though substantial research has been conducted on ICPs…”
Get full text

Exploring the triggering process of a cancer care reform in three Scandinavian countries by Mæhle, Per Magnus, Hajdarevic, Senada, Håland, Erna, Aarhus, Rikke, Smeland, Sigbjørn, Mørk, Bjørn Erik

“…Cancer incidence is increasing, and cancer is a leading cause of death in the Scandinavian countries, and at the same time more efficient but very expensive…”
Get full text

Practicing Integrated Care Pathways in Norwegian Hospitals: Coordination through Industrialized Standardization, Value Chains, and Quality Management or an Organizational Equivalent to Improvised Jazz Standards by Mæhle, Per Magnus, Small Hanto, Ingrid Kristine, Smeland, Sigbjørn

“…The goal of coordinating pathways for cancer patients through their diagnostic and treatment journey is often approached by borrowing strategies from…”
Get full text

Associations of the 2018 World Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR) cancer prevention recommendations with stages of colorectal carcinogenesis by Kværner, Ane Sørlie, Andersen, Astrid Riseth, Henriksen, Hege Berg, Knudsen, Markus Dines, Johansen, Anne Marte Wetting, Hjartåker, Anette, Bøhn, Siv Kjølsrud, Paur, Ingvild, Wiedswang, Gro, Smeland, Sigbjørn, Rounge, Trine B., Blomhoff, Rune, Berstad, Paula

“…Background While adherence to cancer prevention recommendations is linked to lower risk of colorectal cancer (CRC), few have studied associations across the…”
Get full text

IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results by Puco, Katarina, Fagereng, Gro Live, Brabrand, Sigmund, Niehusmann, Pitt, Støre Blix, Egil, Samdal Steinskog, Eli Sihn, Haug, Åse, Fredvik Torkildsen, Cecilie, Oppedal, Irja Alida, Meltzer, Sebastian, Flobak, Åsmund, Johansson, Kajsa Anna Margareta, Bjørge, Line, Hjortland, Geir Olav, Dalhaug, Astrid, Lund, Jo-Åsmund, Gilje, Bjørnar, Grønlie Cameron, Marte, Hovland, Randi, Falk, Ragnhild S, Smeland, Sigbjørn, Giercksky Russnes, Hege Elisabeth, Taskén, Kjetil, Helland, Åslaug

“…In Norway, comprehensive molecular tumour profiling is implemented as part of the public healthcare system. A substantial number of tumours harbour potentially…”
Get full text

Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53 by Høland, Maren, Kolberg, Matthias, Danielsen, Stine Aske, Bjerkehagen, Bodil, Eilertsen, Ina A., Hektoen, Merete, Mandahl, Nils, van den Berg, Eva, Smeland, Sigbjørn, Mertens, Fredrik, Sundby Hall, Kirsten, Picci, Piero, Sveen, Anita, Lothe, Ragnhild A.

“…Malignant peripheral nerve sheath tumor is a rare and aggressive disease with poor treatment response, mainly affecting adolescents and young adults. Few…”
Get full text

Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups by FERRARI, Stefano, SMELAND, Sigbjorn, MÜLLER, Cristoph, TIENGHI, Amelia, WIEBE, Thomas, COMANDONE, Alessandro, BÖHLING, Tom, BRACH DEL PREVER, Adalberto, BROSJÖ, Otte, BACCI, Gaetano, SOETER, Gunnar, MERCURI, Mario, BERTONI, Franco, LONGHI, Alessandra, RUGGIERI, Pietro, ALVEGARD, Thor A, PICCI, Piero, CAPANNA, Rodolfo, BERNINI, Gabriella

“…To explore the effect of high-dose ifosfamide in first-line treatment for patients < or = 40 years of age with nonmetastatic osteosarcoma of the extremity…”
Get full text